If you would like to apply for the position of an Editorial Board Member/Reviewer on the journal, please contact the Editor including your CV and a brief covering letter detailing why you are a suitable candidate, to firstname.lastname@example.org. Your cover letter should be no longer than the one page and should cover where you believe the research field is going (and the journal's place within it), as well as details of any previous relevant journal editorial and peer review management experience.
Ethics & Policies
The Revista Electronica de Veterinaria (REDVET) is a peer-reviewed journal aimed at providing a platform for researchers to showcase and disseminate high-quality research in the field of Veterinary Sciences (medical and health sector, health, surgery, agriculture , animal husbandry, nutrition, environmental) at regional, national and international levels.
The publication of an article in a peer-reviewed journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of work of the author and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is therefore important to agree upon standards of expected ethical behavior
Journal policies on authorship and contributor ship:
All authors must sign the Author Consent Form. The REDVET follows the recommendations for authorship of the ICMJE (www.icmje.org/icmje-recommendations.pdf).
The ‘Uniform Requirements’ of the ICMJE presents authorship recommendations as follows. “Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; and 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring that the questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.” The authors should meet these 4 conditions. All individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.
The contribution of each author must be stated according to the CRediT (Contrubutor Roles Taxonomy) Taxonomy of author roles (casrai.org/credit/) and presented on the title page. If a person does not meet the above four criteria, they may be mentioned as a contributor to the manuscript’s acknowledgments section.
Examples of author contributions
Conceptualization: name; Data curation: name; Formal analysis: name; Funding acquisition: name; Investigation: name; Methodology: name; Project administration: name; Resources: name; Software: name; Supervision: name; Validation: name; Visualization: name; Writing - original draft: name; Writing - review & editing: name.
The Editor assumes that all author(s) listed in a manuscript have agreed with the following REDVET policies on manuscript submission: 1) The manuscript submitted to the REDVET must be previously unpublished and not be under consideration for publication elsewhere; 2) the identities of referees will not be revealed under any circumstances; and 3) if an author(s) should be added or deleted after submission of manuscript, it is the responsibility of the corresponding author to ensure that all the authors involved are aware of and agree to the change in authorship. REDVET has no responsibility for such changes.
How the journal will handle complaints and appeals:
The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from: https://publicationethics.org/appeals.
Who complains or makes an appeal?
Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform the cases, they can send a letter to the editor. For the complaints or appeals, concrete data with answers to all factual questions (who, when, where, what, how, why) should be provided.
Who is responsible to resolve and handle complaints and appeals?
The Editor, Editorial Board, or Editorial Office is responsible for them.
What may be the consequence of remedy? It depends on the type or degree of misconduct. The consequence of resolution will follow the guidelines of the Committee on Publication Ethics (COPE).
iii. Journal policies on conflicts of interest / competing interests:
The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest that may possibly influence the research or interpretation of data. A potential conflict of interest should be disclosed in a ‘Disclosure’ statement, and in the cover letter even when the authors are confident that their judgments have not been influenced during the study or in preparing the manuscript. Such conflicts may include financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems.
The submitted Disclosure format shall follow that of the International Committee of Medical Journal Editors (ICMJE) Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/about-icmje/faqs/conflict-of-interest-disclosure-forms/). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. REDVET asks referees to let the Editor know of any conflict of interest before undertaking a review of a given manuscript.
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal, or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence or be perceived to influence their work.
Journal policies on data sharing and reproducibility:
Open data policy: For clarification on result accuracy and reproducibility of the results, raw data or analysis data will be deposited to a public repository after acceptance of the manuscript. Therefore, the submission of the raw data or analysis data is mandatory. If the data is already a public one, its URL site or sources should be disclosed. If data cannot be publicized, it can be negotiated with the editor. If there are any inquiries on depositing data or waiver of data sharing, the authors should contact the editorial office. Clinical data sharing policy: This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002315&type=printable).
The ICMJE's policy regarding trial registration is explained at
If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.
Journal's policy on ethical oversight:
When the Journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, and ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the Committee on Publication Ethics (https://publicationethics.org/resources/flowcharts). All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB).
Animal experiments should be reviewed by an appropriate committee for the care and use of animals (i.e., an Institutional Animal Care and Use Committee; IACUC). Studies with pathogens requiring a high degree of biosafety should pass the review of a relevant committee (i.e., an Institutional Biosafety Committee; IBC). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
Journal's options for post-publication discussions and corrections:
The post-publication discussion is available through letter to editor. If any readers have a concern on any articles published, they can submit letter to editor on the articles. If there founds any errors or mistakes in the article, it can be corrected through erratum, corrigenda, or retraction.